graph Evidence gap map comparisons
antibody–drug conjugate
trastuzumab emtansine
la/mBC - HER2 positive - 2nd Line (L2) 13   
Comparator:  vs lapatinib plus capecitabine; 
Risk of bias:  low;   some concerns;   high;  NA;